Search Results - guangrong+zheng

6 Results Sort By:
Method of Treating Obesity-Induced Glucose Intolerance and Liver Fibrosis (UCLA Case No. 2021-323)
UCLA researchers in the School of Engineering have discovered a novel method to treat obesity-induced glucose intolerance and liver fibrosis. BACKGROUND: The CDC reports that 41.9% of adults ages 20 and over are obese. An increased incidence of obesity also increases the rates of comorbidities such at type 2 diabetes mellitus (T2DM), non-alcoholic...
Published: 9/24/2024   |   Inventor(s): Zhen Gu
Keywords(s): glucose intolerance, liver fibrosis, Nanoparticles, Notch signaling pathway, obesity
Category(s): Therapeutics > Metabolism And Endocrinology
Anticancer Compounds That Selectively Target and Destroy Cancer-Related Proteins
Demonstrates In Vivo Safety and Efficacy in Breast Cancer Models This set of anticancer compounds selectively degrades or inhibits cancer-related histone deacetylase proteins. These proteins are commonly overexpressed in various cancer types, and class I histone deacetylase proteins activate oncogenes that cause tumor formation, cancer progression,...
Published: 12/1/2021   |   Inventor(s): Daiqing Liao, Xuan Zhang, Yufeng Xiao, William Roush, Ryan Stowe, Guangrong Zheng
Keywords(s):  
Category(s): Technology Classifications > Human Health Care > Therapeutics
2020-179 A METHOD TO PREPARE DEAD TUMOR CELLS AND USE THEREOF
SUMMARYUCLA researchers in the Department of Bioengineering have developed a novel method to generate dead tumors cells for use in cancer therapeutics.BACKGROUNDCancer is a deadly disease that causes approximately 10 million yearly deaths across the globe. While solid tumors may often be fully resected by surgery, the treatment of hematologic malignancies...
Published: 9/5/2023   |   Inventor(s): Zhen Gu
Keywords(s): Medical Devices and Materials, Oncology, Therapeutics & Vaccines
Category(s): Therapeutics > Oncology
Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery (UCLA Case No. 2021-116)
Summary: UCLA researchers in the department of Bioengineering have developed a biodegradable material that is capable of releasing insulin in the presence of excess glucose mimicking the insulin secretion properties of pancreatic B-cells as a treatment for Diabetes Mellitus.Background: Diabetes mellitus currently affects more than 463 million people...
Published: 8/9/2024   |   Inventor(s): Zhen Gu
Keywords(s):  
Category(s): Platforms > Drug Delivery > Other Polymers, Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Metabolism And Endocrinology
2020-854 DUAL SELF-REGULATED DELIVERY OF INSULIN AND GLUCAGON BY A HYBRID PATCH
UCLA researchers have developed a novel hybrid microneedle patch that can deliver insulin and glucagon in a glucose-dependent manner. BACKGROUND: Type I diabetes (T1D) is an autoimmune disease in which pancreatic -cells are destroyed and there is a deficiency is insulin secretion. Type 2 diabetes (T2D) is a metabolic disorder resulting from insulin...
Published: 7/19/2023   |   Inventor(s): Zhen Gu
Keywords(s): Drug Delivery, Medical Devices and Materials, Metabolic Diseases, Other Polymers, Polymers, Therapeutics & Vaccines
Category(s): Medical Devices, Platforms > Drug Delivery, Therapeutics, Platforms > Drug Delivery > Other Polymers, Therapeutics > Metabolism And Endocrinology
2020-178 COLD ATMOSPHERIC PLASMA TREATMENT FOR CANCER IMMUNOTHERAPY
UCLA researchers in the Department of Bioengineering have developed a novel cancer treatment using a combination of microneedle patch-assisted cold atmospheric plasma and checkpoint blockade.BACKGROUND: Immunotherapy revolutionizes cancer treatment by harnessing the power of the immune system for fighting cancer. Among all immunotherapeutic strategies,...
Published: 7/19/2023   |   Inventor(s): Zhen Gu, Richard Wirz, Guojun Chen, Zhitong Chen
Keywords(s): Medical Devices and Materials, Oncology, Oncology Immunotherapy, Therapeutics & Vaccines
Category(s): Therapeutics > Oncology, Therapeutics > Oncology > Oncology Immunotherapy